Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers

PurposeThe present retrospective analysis sought to compare the relative diagnostic efficacy of [68Ga]Ga-DOTA-FAPI-04 to that of [18F]FDG PET/CT as a means of detecting bone metastases in patients with a range of cancer types.MaterialsIn total, 30 patients with bone metastases associated with differ...

Full description

Bibliographic Details
Main Authors: Junhao Wu, Yingwei Wang, Taiping Liao, Zijuan Rao, Weidong Gong, Lei Ou, Yue Chen, Chunyin Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.737827/full
_version_ 1828916105440133120
author Junhao Wu
Junhao Wu
Junhao Wu
Yingwei Wang
Yingwei Wang
Yingwei Wang
Taiping Liao
Taiping Liao
Taiping Liao
Zijuan Rao
Zijuan Rao
Zijuan Rao
Weidong Gong
Weidong Gong
Weidong Gong
Lei Ou
Lei Ou
Lei Ou
Yue Chen
Yue Chen
Yue Chen
Chunyin Zhang
Chunyin Zhang
Chunyin Zhang
author_facet Junhao Wu
Junhao Wu
Junhao Wu
Yingwei Wang
Yingwei Wang
Yingwei Wang
Taiping Liao
Taiping Liao
Taiping Liao
Zijuan Rao
Zijuan Rao
Zijuan Rao
Weidong Gong
Weidong Gong
Weidong Gong
Lei Ou
Lei Ou
Lei Ou
Yue Chen
Yue Chen
Yue Chen
Chunyin Zhang
Chunyin Zhang
Chunyin Zhang
author_sort Junhao Wu
collection DOAJ
description PurposeThe present retrospective analysis sought to compare the relative diagnostic efficacy of [68Ga]Ga-DOTA-FAPI-04 to that of [18F]FDG PET/CT as a means of detecting bone metastases in patients with a range of cancer types.MaterialsIn total, 30 patients with bone metastases associated with different underlying malignancies were retrospectively enrolled. All patients had undergone [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT, and the McNemar test was used to compare the relative diagnostic performance of these two imaging modalities. The maximum standard uptake value (SUVmax) was used to quantify radiotracer uptake by metastatic lesions, with the relative uptake associated with these two imaging strategies being compared via the Mann-Whitney U test. The cohort was further respectively divided into two (osteolytic and osteoblastic bone metastases) and three clinical subgroups (lung cancer, thyroid cancer, and liver cancer).Results[68Ga]Ga-DOTA-FAPI-04 PET/CT was found to be significantly more sensitive as a means of diagnosing bone metastases relative to [18F]FDG PET/CT ([109/109] 100% vs [89/109] 81.7%; P< 0.01), consistent with the significantly increased uptake of [68Ga]Ga-DOTA-FAPI-04 by these metastatic lesions relative to that of [18F]FDG (n=109, median SUVmax, 9.1 vs. 4.5; P< 0.01). [68Ga]Ga-DOTA-FAPI-04 accumulation was significantly higher than that of [18F]FDG in both osteolytic (n=66, median SUVmax, 10.6 vs 6.1; P < 0.01), and osteoblastic metastases (n=43, median SUVmax, 7.7 vs 3.7; P < 0.01). [68Ga]Ga-DOTA-FAPI-04 uptakes were significantly higher than that of [18F]FDG in bone metastases from lung cancer (n = 62, median SUVmax, 10.7 vs 5.2; P < 0.01), thyroid cancer (n = 18, median SUVmax, 5.65 vs 2.1; P < 0.01) and liver cancer (n = 12, median SUVmax, 5.65 vs 3.05; P < 0.01). However, [68Ga]Ga-DOTA-FAPI-04 detected 10 false-positive lesions, while only 5 false-positive were visualized by [18F]FDG PET/CT.Conclusion[68Ga]Ga-DOTA-FAPI-04 PET/CT exhibits excellent diagnostic performance as a means of detecting bone metastases, and is superior to [18F]FDG PET/CT in this diagnostic context. Furthermore, [68Ga]Ga-DOTA-FAPI-04 tracer uptake levels are higher than those of [18F]FDG for most bone metastases. However, owing to the potential for false-positive bone lesions, it is critical that physicians interpret all CT findings with caution to ensure diagnostic accuracy.
first_indexed 2024-12-13T20:26:41Z
format Article
id doaj.art-a90fbdc5c5364dd2a335414c1f21e9cd
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-13T20:26:41Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-a90fbdc5c5364dd2a335414c1f21e9cd2022-12-21T23:32:33ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-09-011110.3389/fonc.2021.737827737827Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different CancersJunhao Wu0Junhao Wu1Junhao Wu2Yingwei Wang3Yingwei Wang4Yingwei Wang5Taiping Liao6Taiping Liao7Taiping Liao8Zijuan Rao9Zijuan Rao10Zijuan Rao11Weidong Gong12Weidong Gong13Weidong Gong14Lei Ou15Lei Ou16Lei Ou17Yue Chen18Yue Chen19Yue Chen20Chunyin Zhang21Chunyin Zhang22Chunyin Zhang23Department of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, ChinaNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, ChinaAcademician (Expert) Workstation of Sichuan Province, Luzhou, ChinaDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, ChinaNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, ChinaAcademician (Expert) Workstation of Sichuan Province, Luzhou, ChinaDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, ChinaNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, ChinaAcademician (Expert) Workstation of Sichuan Province, Luzhou, ChinaDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, ChinaNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, ChinaAcademician (Expert) Workstation of Sichuan Province, Luzhou, ChinaDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, ChinaNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, ChinaAcademician (Expert) Workstation of Sichuan Province, Luzhou, ChinaDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, ChinaNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, ChinaAcademician (Expert) Workstation of Sichuan Province, Luzhou, ChinaDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, ChinaNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, ChinaAcademician (Expert) Workstation of Sichuan Province, Luzhou, ChinaDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, ChinaNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, ChinaAcademician (Expert) Workstation of Sichuan Province, Luzhou, ChinaPurposeThe present retrospective analysis sought to compare the relative diagnostic efficacy of [68Ga]Ga-DOTA-FAPI-04 to that of [18F]FDG PET/CT as a means of detecting bone metastases in patients with a range of cancer types.MaterialsIn total, 30 patients with bone metastases associated with different underlying malignancies were retrospectively enrolled. All patients had undergone [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT, and the McNemar test was used to compare the relative diagnostic performance of these two imaging modalities. The maximum standard uptake value (SUVmax) was used to quantify radiotracer uptake by metastatic lesions, with the relative uptake associated with these two imaging strategies being compared via the Mann-Whitney U test. The cohort was further respectively divided into two (osteolytic and osteoblastic bone metastases) and three clinical subgroups (lung cancer, thyroid cancer, and liver cancer).Results[68Ga]Ga-DOTA-FAPI-04 PET/CT was found to be significantly more sensitive as a means of diagnosing bone metastases relative to [18F]FDG PET/CT ([109/109] 100% vs [89/109] 81.7%; P< 0.01), consistent with the significantly increased uptake of [68Ga]Ga-DOTA-FAPI-04 by these metastatic lesions relative to that of [18F]FDG (n=109, median SUVmax, 9.1 vs. 4.5; P< 0.01). [68Ga]Ga-DOTA-FAPI-04 accumulation was significantly higher than that of [18F]FDG in both osteolytic (n=66, median SUVmax, 10.6 vs 6.1; P < 0.01), and osteoblastic metastases (n=43, median SUVmax, 7.7 vs 3.7; P < 0.01). [68Ga]Ga-DOTA-FAPI-04 uptakes were significantly higher than that of [18F]FDG in bone metastases from lung cancer (n = 62, median SUVmax, 10.7 vs 5.2; P < 0.01), thyroid cancer (n = 18, median SUVmax, 5.65 vs 2.1; P < 0.01) and liver cancer (n = 12, median SUVmax, 5.65 vs 3.05; P < 0.01). However, [68Ga]Ga-DOTA-FAPI-04 detected 10 false-positive lesions, while only 5 false-positive were visualized by [18F]FDG PET/CT.Conclusion[68Ga]Ga-DOTA-FAPI-04 PET/CT exhibits excellent diagnostic performance as a means of detecting bone metastases, and is superior to [18F]FDG PET/CT in this diagnostic context. Furthermore, [68Ga]Ga-DOTA-FAPI-04 tracer uptake levels are higher than those of [18F]FDG for most bone metastases. However, owing to the potential for false-positive bone lesions, it is critical that physicians interpret all CT findings with caution to ensure diagnostic accuracy.https://www.frontiersin.org/articles/10.3389/fonc.2021.737827/fullbone metastases[68Ga]Ga-DOTA-FAPI-04[18F]FDGPET/CTcancer
spellingShingle Junhao Wu
Junhao Wu
Junhao Wu
Yingwei Wang
Yingwei Wang
Yingwei Wang
Taiping Liao
Taiping Liao
Taiping Liao
Zijuan Rao
Zijuan Rao
Zijuan Rao
Weidong Gong
Weidong Gong
Weidong Gong
Lei Ou
Lei Ou
Lei Ou
Yue Chen
Yue Chen
Yue Chen
Chunyin Zhang
Chunyin Zhang
Chunyin Zhang
Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
Frontiers in Oncology
bone metastases
[68Ga]Ga-DOTA-FAPI-04
[18F]FDG
PET/CT
cancer
title Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
title_full Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
title_fullStr Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
title_full_unstemmed Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
title_short Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
title_sort comparison of the relative diagnostic performance of 68ga ga dota fapi 04 and 18f fdg pet ct for the detection of bone metastasis in patients with different cancers
topic bone metastases
[68Ga]Ga-DOTA-FAPI-04
[18F]FDG
PET/CT
cancer
url https://www.frontiersin.org/articles/10.3389/fonc.2021.737827/full
work_keys_str_mv AT junhaowu comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT junhaowu comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT junhaowu comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT yingweiwang comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT yingweiwang comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT yingweiwang comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT taipingliao comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT taipingliao comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT taipingliao comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT zijuanrao comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT zijuanrao comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT zijuanrao comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT weidonggong comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT weidonggong comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT weidonggong comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT leiou comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT leiou comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT leiou comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT yuechen comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT yuechen comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT yuechen comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT chunyinzhang comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT chunyinzhang comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers
AT chunyinzhang comparisonoftherelativediagnosticperformanceof68gagadotafapi04and18ffdgpetctforthedetectionofbonemetastasisinpatientswithdifferentcancers